Intellectual Property India Publishes Patent Application for Ai Models, Systems, And Methods For Manufacturing Car T Drug Products With Improved Viability

MUMBAI, India, July 13 -- Intellectual Property India has published a patent application (202617071977 A) filed by Janssen Biotech, Inc. on June 10, 2026, for Ai Models, Systems, And Methods For Manufacturing Car T Drug Products With Improved Viability.

Inventors include Magge Ranganatha, Arjun; Javidi, Alex; Lu, Hoang; Henckels, Eric; Yang, Katherine; Berk, Erik Number; Shen, Dee; Sztanka-Toth, Tamas; Ciccone, Daniel; Morris, Donald; and Bowden, Robert.

The application for the patent was published on July 10, 2026, under issue no. 28/2026.

Abstract: Systems and methods are disclosed for predicting patient-specific CAR T drug product viability and optimizing CAR T drug manufacturing. An example method includes: receiving quantitative data for a set of viability parameters; generating an input feature vector comprising the quantitative data for the set of CAR-T drug viability parameters; and applying, into a trained machine learning model, the input feature vector to generate an output feature vector predicting a patient-specific CAR T drug product viability of a CAR T drug product for a target patient.

Disclaimer: Curated by HT Syndication.